Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer with High-Risk Features Following Radical Prostatectomy

Key Points

• Prostate bed stereotactic body radiation therapy improves outcomes in high-risk prostate cancer patients, enhancing recovery.
• The primary efficacy assessment shows a significant 50% reduction in cancer recurrence after treatment.
• Phase II clinical trial explores the effectiveness of targeted radiation therapy in post-surgical patients.
• Support for innovative therapies highlights the need for further studies in larger populations to confirm these findings.